GENE ONLINE|News &
Opinion
Blog

Trials & Approvals
COVID-19 Antibody
FDA Grants Emergency Use Authorization to Third COVID-19 Antibody Therapy
2021-05-27
Trials & Approvals CTI-1601
Larimar Drops $95M Private Financing Plans after FDA Orders Clinical Hold on Rare Disease Therapy
2021-05-27
Trials & Approvals EGFR
FDA Approves First Targeted Therapy for EGFR Lung Cancer with Exon 20 Mutations
2021-05-24
Trials & Approvals Gene Therapy
Sarepta to Begin Phase 3 Rivalry with Pfizer after its DMD Gene Therapy Registers Encouraging Data
2021-05-21
COVID-19 Vaccine
SK Bioscience Receives EU-GMP Certification for COVID-19 Vaccine Production Plant, Making it Korea’s First
2021-05-18
COVID-19 Vaccine
Sanofi, GSK Report Positive Trial Data for COVID-19 Vaccine
2021-05-18
COVID-19 mRNA Vaccine
FDA Authorizes Pfizer/BioNTech’s COVID-19 Vaccine for 12 to 15 Year Olds
2021-05-11
COVID-19 2-deoxy-D-glucose
India Approves Oral COVID-19 Drug for Emergency Use to Abate Oxygen Crisis
2021-05-09
Trials & Approvals Avrobio
Full Approval of Treatment Standard Forces Avrobio to Adjust Fabry Disease Therapy Plans
2021-05-04
Trials & Approvals Type 2 Diabetes
FDA Greenlights AstraZeneca’s Blockbuster Drug for Chronic Kidney Disease
2021-05-02
Trials & Approvals Rare Disease
FDA Rejects Protalix’s Enzyme Replacement Therapy for Rare Genetic Disease
2021-04-29
Trials & Approvals Cancer
GSK’s Oncology Drug Acquired from Tesaro Notches Accelerated Approval for Endometrial Cancer
2021-04-25
COVID-19 Immunoassay
Celltrion Bags FDA’s Emergency Approval for COVID-19 Rapid Test, Prepares to Ship Supply to the US
2021-04-21
Trials & Approvals Gastric Cancer
BMS’s Drug Bags First FDA-Approved Immunotherapy Tag for Initial Treatment of Gastric Cancer
2021-04-19
Trials & Approvals Asthma
Novartis, Genentech Bag Key FDA Okay for Blockbuster Drug
2021-04-14
1 … 28 29 30 31 32 … 50
LATEST
The Gene & Cell Therapy Landscape: Recent Approvals and Upcoming Therapeutics of Interest
2024-05-06
Exploring Key Areas of RNA Therapeutics Development: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Mastering Gene & Cell Therapy: Your Blueprint for Maximizing ASGCT Content
2024-05-06
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top